健之佳医药连锁集团股份有限公司关于实际控制人的一致行动人权益变动触及1%刻度的提示性公告

Core Viewpoint - Yunnan Xiangqun Investment Co., Ltd., controlled by Mr. Lan Bo, plans to increase its stake in Jianzhijia Pharmaceutical Chain Group Co., Ltd. by investing 50 million yuan over a six-month period starting January 1, 2026, through the Shanghai Stock Exchange [1] Group 1: Shareholding Changes - Yunnan Xiangqun and its concerted actors increased their holdings by 1,362,313 shares from February 4 to February 24, 2026, representing 0.88% of the total share capital [2] - As of the announcement date, Yunnan Xiangqun directly holds 15,180,612 shares, accounting for 9.82% of the total share capital [2] Group 2: Compliance and Regulations - The shareholding increase complies with the Securities Law of the People's Republic of China and relevant regulations, exempting it from the obligation to issue a tender offer as it does not exceed 2% of the total share capital [3] - The increase in shareholding will not affect the company's listing status or the distribution of its shares, nor will it lead to changes in the actual controller or major shareholder [3] - The company will continue to monitor the shareholding changes and fulfill its information disclosure obligations as per relevant regulations [3]